纳米碳染色在N0期乳头状甲状腺癌颈部淋巴结清扫中的应用

高庆军, 赵代伟. 纳米碳染色在N0期乳头状甲状腺癌颈部淋巴结清扫中的应用[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(24): 1938-1940. doi: 10.13201/j.issn.1001-1781.2014.24.009
引用本文: 高庆军, 赵代伟. 纳米碳染色在N0期乳头状甲状腺癌颈部淋巴结清扫中的应用[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(24): 1938-1940. doi: 10.13201/j.issn.1001-1781.2014.24.009
GAO Qingjun, ZHAO Daiwei. Clinical application of carbon nanoparticles labeled lymph node in cervical lymph node dissection with papillary thyroid cancer staged preoperatively as N0[J]. J Clin Otorhinolaryngol Head Neck Surg, 2014, 28(24): 1938-1940. doi: 10.13201/j.issn.1001-1781.2014.24.009
Citation: GAO Qingjun, ZHAO Daiwei. Clinical application of carbon nanoparticles labeled lymph node in cervical lymph node dissection with papillary thyroid cancer staged preoperatively as N0[J]. J Clin Otorhinolaryngol Head Neck Surg, 2014, 28(24): 1938-1940. doi: 10.13201/j.issn.1001-1781.2014.24.009

纳米碳染色在N0期乳头状甲状腺癌颈部淋巴结清扫中的应用

详细信息
    通讯作者: 赵代伟,E-mail:zhaodw@hotmail.com
  • 中图分类号: R736.1

Clinical application of carbon nanoparticles labeled lymph node in cervical lymph node dissection with papillary thyroid cancer staged preoperatively as N0

More Information
  • 目的:探讨纳米碳示踪剂在甲状腺乳头状癌(cN0期)颈部淋巴结清扫中的应用价值。方法:将100例符合入选标准的甲状腺乳头状癌(cN0期)患者随机分为纳米碳组(50例)和常规手术组(50例),两组患者均予腺叶切除、甲状腺近全切除或甲状腺全切除,均进行中央区淋巴结清扫,统计各组检获淋巴结数,并将纳米碳组检获的淋巴结按染色与未染色统计,分别进行病理检查。结果:纳米碳组每例检出淋巴结数明显高于常规手术组(P<0.05);纳米碳组每例检出转移淋巴结枚数高于常规手术组(P<0.01)。100例患者中有2%出现了暂时性声嘶,8%暂时性甲状旁腺功能低下,无永久性声嘶及永久性甲状旁腺功能低下等并发症。结论:纳米碳淋巴结示踪剂染色效果良好,术中易识别,能指导手术医师术中正确制定手术方案进行淋巴结清除。
  • 加载中
  • [1]

    章阳, 崔兆清, 孙善平, 等.分化型甲状腺癌行颈部淋巴结清扫的意义及方式探讨[J].中国实用外科杂志, 2011, 31 (5):414-416.

    [2]

    滕卫平, 刘永锋, 高明, 等.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床, 2012, 39 (17):1249-1272.

    [3]

    BAEK S K, JUNG K Y, KANG S M, et al.Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma[J].Thyroid, 2010, 20:147-152.

    [4]

    马宏岩, 李迅庚.甲状腺乳头状癌选择性颈淋巴结清除术的临床研究[J].中华肿瘤防治研究, 2008, 15 (6):453-455.

    [5]

    KOUVARAKI M A, SHAPIRO S E, FORNAGE B D, et al.Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer[J].Surgery, 2003, 134:946-955.

    [6]

    PODNOS Y D, SMITH D, WAGMAN L D, et al.The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer[J].Am Surg, 2005, 71:731-734.

    [7]

    LUNDGREN C I, HALL P, DICKMAN P W, et al.Clinically significant prognostic factors for differentiated thyroid carcinoma:a population-based, nested case-control study[J].Cancer, 2006, 106:524-531.

    [8]

    HAGIWARA A, TORII T, SAWAI K, et al.Local injection of anti-cancer drugs bound to carbon particles for early gastric cancer——apilot study[J].Hepatogastroenterology, 2000, 47:575-578.

    [9]

    林周, 鲍传庆, 俞宪民, 等.纳米碳标记淋巴结和前哨淋巴结的活检在大肠癌根治术应用研究[J].实用临床药物杂志, 2007, 11 (9):80-81.

    [10]

    李伟, 徐亮.纳米碳在胃癌淋巴靶向化疗中的应用研究进展[J].泸州医学院学报, 2009, 32 (4):439-441.

    [11]

    张筱骅, 郝儒田, 尤捷, 等.甲状腺淋巴管造影在鉴别甲状旁腺中的意义[J].温州医学院学报, 2010, 40 (1):31-35.

  • 加载中
计量
  • 文章访问数:  217
  • PDF下载数:  143
  • 施引文献:  0
出版历程
收稿日期:  2014-03-27

目录